SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Threshold is a project merged from the NuCypher and Keep networks, which strives to provide different threshold cryptography solutions in a fully decentralized manner to the web3 community. Threshold cryptography is a technology that uses cryptography to unlock greater utility and usability for digital assets without needing to trust a centralized party. Threshold cryptography distributes sensitive operations across multiple independent entities – like nodes in a network – and requires a threshold, or minimum number of those entities to cooperate for the operation to be successful.

Threshold Network Token

Threshold Network Token (T) is trending amidst significant community buzz, fueled by recent exchange availability and strong speculation regarding its tBTC solution. Many believe it offers a decentralized alternative for bringing Bitcoin into DeFi, with discussions highlighting its potential to disrupt existing wrapped Bitcoin offerings and lead to substantial growth.

Banco Santander SA is a banking services company, which engages in the provision of banking services to individuals, companies, and institutions. It operates through the following segments: Retail & Commercial Banking, Digital Consumer Bank, Corporate & Investment Banking, Wealth Management & Insurance, Payments, and Corporate Centre. The Retail & Commercial Banking segment integrates the retail banking business (individuals) and commercial banking (SMEs and corporates), except for the consumer finance and the cards businesses. The Digital Consumer Bank segment includes Santander Consumer Finance, which incorporates the entire consumer finance business in Europe, Openbank, and ODS. The Corporate & Investment Banking segment includes Markets, Investment Banking (Global Debt Finance and Corporate Finance) and Global Transactional Banking, offers products and services on a global scale to corporate and institutional customers, and collaborates with other global businesses to better serve broad customer base. The Wealth Management & Insurance segment includes the asset management business (Santander Asset Management), the corporate unit of Private Banking and International Private Banking in Miami and Switzerland and the insurance business (Santander Insurance). The Payments segment involves in the digital payment's solutions, providing global technology solutions for banks and new customers in the open market. The Corporate Centre segment includes the centralized activities relating to equity stakes in financial companies, financial management of the structural exchange rate position. The company was founded on March 21, 1857 and is headquartered in Madrid, Spain.

Banco Santander S.A. - ADR

Banco Santander

Banco Santander is attracting significant attention amid its strategic global repositioning, marked by the divestment of its Polish banking operations and an assertive expansion into the Americas, including a new Canadian banking license and a U.S. partnership with Verizon. The community is actively discussing the bank's strong performance, geographic diversification, and benefits from widening net interest margins across Europe and Latin America, fueling a bullish sentiment despite some technical warnings of being overbought.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is drawing significant attention amid concerns over a spreading severe flu variant and potential bird flu risks, highlighting its mRNA vaccine candidates. Despite a recent market reaction to mixed interim cystic fibrosis data, many perceive the sell-off as overdone, focusing on positive biological signals like mucus plug reduction for an underserved patient group. The community is actively debating the stock's undervaluation, the impact of a trade secret lawsuit against AbbVie, and the potential for a short squeeze as key drivers.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly (FSLY) is drawing attention following KeyBanc's upgrade, a planned Nasdaq listing, and recent strong financial results that showcase record profitability and free cash flow. While some investors are optimistic about its edge computing capabilities, AI security products, and potential for a significant TikTok partnership, others remain cautious due to historical volatility and a recent convertible notes offering. Community discussions frequently pit Fastly's future growth against larger competitors like Cloudflare, emphasizing its potential for a turnaround.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

Silver (SLV) is experiencing a historic, parabolic rally, primarily fueled by strong industrial demand for green technology and AI, alongside China's impending export restrictions on the metal. This surge has ignited intense debate within the community, with many anticipating a significant short squeeze and a multi-year 'generational run' driven by physical supply shortages. However, others caution that the rally is an unsustainable 'blow-off top,' noting increased COMEX margin requirements as a potential indicator of an impending correction.

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is experiencing renewed interest due to surging demand for decentralized data storage from AI and Web3 projects, with recent network upgrades, record-high storage deals, and a strong presence in the DePIN sector driving conversation. The community views $FIL as a crucial, yet undervalued, piece of infrastructure, actively discussing its potential for significant growth as a foundational layer for verifiable and censorship-resistant data.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending as it fortifies its pipeline with successful HIV treatment advancements and strategic oncology acquisitions, notably licensing Assembly Bio's herpes programs and acquiring a Repare Therapeutics cancer asset. Despite these gains, community sentiment is nuanced due to a setback in its Trodelvy cancer trial and CVS Health's recent decision regarding coverage for its new HIV prevention treatment, Yeztugo.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is a focal point of discussion following a market reaction to recently adjusted guidance and a CFO transition, which prompted a notable price decline and high trading volume. Many investors view this as an overreaction, highlighting the company's robust annual recurring revenue, positive free cash flow, and strong position in the AI-native cybersecurity sector as indicators of undervaluation. This sentiment fuels frequent community speculation about its potential as an acquisition target or a significant rebound in value over the coming years.

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

Medline Inc - Ordinary Shares - Class A

Medline Inc.

Medline is trending following its recent and notably successful IPO, marking it as the largest offering of 2025 and sparking significant market conversation. The community is actively discussing its strong fundamentals as an essential medical supplies provider, positioning it as a stable, long-term investment within the healthcare sector. This debut is largely seen as a positive indicator for investor confidence in established, financially robust companies, contrasting with the volatility often seen in other sectors.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is buzzing after securing multiple key FDA approvals for its cancer treatment Libtayo, expanded indications for EYLEA HD, and a pediatric label for Evkeeza, alongside breakthrough gene therapy trial results. This strong pipeline momentum and an earnings beat are fueling a largely bullish community sentiment, with many investors viewing the biopharmaceutical giant as a compelling long-term hold despite some lingering manufacturing-related concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
